Kazia Therapeutics Limited American Depositary Shares

KZIA

...

KZIA: Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors.

Show KZIA Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of KZIA by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by KZIA's directors and management

No recent Insider Trading for this ticker

Insider Trading Dashboard

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

Patent Title: Functionalised benzopyran compounds and use thereof Aug. 06, 2019

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on KZIA's company Twitter account

WallStreetBets

Number of mentions of KZIA in WallStreetBets Daily Discussion

KZIA News

Recent insights relating to KZIA

CNBC Recommendations

Recent picks made for KZIA stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in KZIA

Corporate Flights

Flights by private jets registered to KZIA